Accord Logo

Intended for UK patients and members of the public

SmPC - Orgovyx® 120 mg film-coated tablets, Relugolix 120 mg film-coated tablets (Great Britain): Change history

  • To update sections 4.2 and 4.5 of the SmPC to add information on "Combination with other medicines for advanced hormone-sensitive prostate cancer" based on clinical studies and literature. In addition, to introduce editorial changes to sections 4.8 and 5.1 of the SmPC.

    • Changes: (Updated: 22 Sep 2022)

      initial upload

    View product information as a: